EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
Open Access
- 1 May 2005
- journal article
- guideline
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 64 (5), 669-681
- https://doi.org/10.1136/ard.2004.028886
Abstract
Objective: To develop evidence based recommendations for the management of hip osteoarthritis (OA). Methods: The multidisciplinary guideline development group comprised 18 rheumatologists, 4 orthopaedic surgeons, and 1 epidemiologist, representing 14 European countries. Each participant contributed up to 10 propositions describing key clinical aspects of hip OA management. Ten final recommendations were agreed using a Delphi consensus approach. Medline, Embase, CINAHL, Cochrane Library, and HTA reports were searched systematically to obtain research evidence for each proposition. Where possible, outcome data for efficacy, adverse effects, and cost effectiveness were abstracted. Effect size, rate ratio, number needed to treat, and incremental cost effectiveness ratio were calculated. The quality of evidence was categorised according to the evidence hierarchy. The strength of recommendation was assessed using the traditional A–D grading scale and a visual analogue scale. Results: Ten key treatment propositions were generated through three Delphi rounds. They included 21 interventions, such as paracetamol, NSAIDs, symptomatic slow acting disease modifying drugs, opioids, intra-articular steroids, non-pharmacological treatment, total hip replacement, osteotomy, and two general propositions. 461 studies were identified from the literature search for the proposed interventions of efficacy, side effects, and cost effectiveness. Research evidence supported 15 interventions in the treatment of hip OA. Evidence specific for the hip was strikingly lacking. Strength of recommendation varied according to category of research evidence and expert opinion. Conclusion: Ten key recommendations for the treatment of hip OA were developed based on research evidence and expert consensus. The effectiveness and cost effectiveness of these recommendations were evaluated and the strength of recommendation was scored.Keywords
This publication has 103 references indexed in Scilit:
- Quality of life after several treatments for osteoarthritis of the hipJournal of Orthopaedic Science, 2003
- Antibiotic prophylaxis for patients undergoing transurethral resection of prostate who have preoperative containing <100,000 bacteria/mLPublished by Wiley ,2002
- Surgical dislocation of the adult hipThe Journal of Bone and Joint Surgery, 2001
- Radiographic stage of osteoarthritis or sex of the patient does not predict one year outcome after total hip arthroplastyAnnals Of The Rheumatic Diseases, 2001
- Herbal therapy for treating osteoarthritisPublished by Wiley ,2000
- Long-term results of rotational acetabular osteotomy in young patients with advanced osteoarthrosis of the hipJournal of Orthopaedic Science, 2000
- Clinical Endoscopic Evaluation of the Gastroduodenal Tolerance to (R)‐ Ketoprofen, (R)‐ Flurbiprofen, Racemic Ketoprofen, and Paracetamol: A Randomized, Single‐Blind, Placebo‐Controlled TrialThe Journal of Clinical Pharmacology, 1998
- Medico-Economic Analysis of Diacerein With or Without Standard Therapy in the Treatment of OsteoarthritisPharmacoEconomics, 1998
- Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hipPublished by Wiley ,1997
- Life expectancy after hip arthroplasty: Case-control study of 1018 cases of primary arthrosisActa Orthopaedica, 1994